323 related articles for article (PubMed ID: 31348886)
1. Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization.
Kong R; Duan H; Sheng Z; Xu K; Acharya P; Chen X; Cheng C; Dingens AS; Gorman J; Sastry M; Shen CH; Zhang B; Zhou T; Chuang GY; Chao CW; Gu Y; Jafari AJ; Louder MK; O'Dell S; Rowshan AP; Viox EG; Wang Y; Choi CW; Corcoran MM; Corrigan AR; Dandey VP; Eng ET; Geng H; Foulds KE; Guo Y; Kwon YD; Lin B; Liu K; Mason RD; Nason MC; Ohr TY; Ou L; Rawi R; Sarfo EK; Schön A; Todd JP; Wang S; Wei H; Wu W; ; Mullikin JC; Bailer RT; Doria-Rose NA; Karlsson Hedestam GB; Scorpio DG; Overbaugh J; Bloom JD; Carragher B; Potter CS; Shapiro L; Kwong PD; Mascola JR
Cell; 2019 Jul; 178(3):567-584.e19. PubMed ID: 31348886
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 Cross-Reactive Primary Virus Neutralizing Antibody Response Elicited by Immunization in Nonhuman Primates.
Wang Y; O'Dell S; Turner HL; Chiang CI; Lei L; Guenaga J; Wilson R; Martinez-Murillo P; Doria-Rose N; Ward AB; Mascola JR; Wyatt RT; Karlsson Hedestam GB; Li Y
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835491
[TBL] [Abstract][Full Text] [Related]
3. Development of a 3Mut-Apex-Stabilized Envelope Trimer That Expands HIV-1 Neutralization Breadth When Used To Boost Fusion Peptide-Directed Vaccine-Elicited Responses.
Chuang GY; Lai YT; Boyington JC; Cheng C; Geng H; Narpala S; Rawi R; Schmidt SD; Tsybovsky Y; Verardi R; Xu K; Yang Y; Zhang B; Chambers M; Changela A; Corrigan AR; Kong R; Olia AS; Ou L; Sarfo EK; Wang S; Wu W; Doria-Rose NA; McDermott AB; Mascola JR; Kwong PD
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295908
[TBL] [Abstract][Full Text] [Related]
4. Consistent elicitation of cross-clade HIV-neutralizing responses achieved in guinea pigs after fusion peptide priming by repetitive envelope trimer boosting.
Cheng C; Xu K; Kong R; Chuang GY; Corrigan AR; Geng H; Hill KR; Jafari AJ; O'Dell S; Ou L; Rawi R; Rowshan AP; Sarfo EK; Sastry M; Saunders KO; Schmidt SD; Wang S; Wu W; Zhang B; Doria-Rose NA; Haynes BF; Scorpio DG; Shapiro L; Mascola JR; Kwong PD
PLoS One; 2019; 14(4):e0215163. PubMed ID: 30995238
[TBL] [Abstract][Full Text] [Related]
5. Immune Monitoring Reveals Fusion Peptide Priming to Imprint Cross-Clade HIV-Neutralizing Responses with a Characteristic Early B Cell Signature.
Cheng C; Duan H; Xu K; Chuang GY; Corrigan AR; Geng H; O'Dell S; Ou L; Chambers M; Changela A; Chen X; Foulds KE; Sarfo EK; Jafari AJ; Hill KR; Kong R; Liu K; Todd JP; Tsybovsky Y; Verardi R; Wang S; Wang Y; Wu W; Zhou T; ; Arnold FJ; Doria-Rose NA; Koup RA; McDermott AB; Scorpio DG; Worobey M; Shapiro L; Mascola JR; Kwong PD
Cell Rep; 2020 Aug; 32(5):107981. PubMed ID: 32755575
[TBL] [Abstract][Full Text] [Related]
6. Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1.
Xu K; Acharya P; Kong R; Cheng C; Chuang GY; Liu K; Louder MK; O'Dell S; Rawi R; Sastry M; Shen CH; Zhang B; Zhou T; Asokan M; Bailer RT; Chambers M; Chen X; Choi CW; Dandey VP; Doria-Rose NA; Druz A; Eng ET; Farney SK; Foulds KE; Geng H; Georgiev IS; Gorman J; Hill KR; Jafari AJ; Kwon YD; Lai YT; Lemmin T; McKee K; Ohr TY; Ou L; Peng D; Rowshan AP; Sheng Z; Todd JP; Tsybovsky Y; Viox EG; Wang Y; Wei H; Yang Y; Zhou AF; Chen R; Yang L; Scorpio DG; McDermott AB; Shapiro L; Carragher B; Potter CS; Mascola JR; Kwong PD
Nat Med; 2018 Jun; 24(6):857-867. PubMed ID: 29867235
[TBL] [Abstract][Full Text] [Related]
7. Conformational Plasticity in the HIV-1 Fusion Peptide Facilitates Recognition by Broadly Neutralizing Antibodies.
Yuan M; Cottrell CA; Ozorowski G; van Gils MJ; Kumar S; Wu NC; Sarkar A; Torres JL; de Val N; Copps J; Moore JP; Sanders RW; Ward AB; Wilson IA
Cell Host Microbe; 2019 Jun; 25(6):873-883.e5. PubMed ID: 31194940
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of a Prefusion HIV-1 Envelope Trimer in Complex with a Quaternary-Structure-Specific Antibody.
Cheng C; Pancera M; Bossert A; Schmidt SD; Chen RE; Chen X; Druz A; Narpala S; Doria-Rose NA; McDermott AB; Kwong PD; Mascola JR
J Virol; 2015 Dec; 90(6):2740-55. PubMed ID: 26719262
[TBL] [Abstract][Full Text] [Related]
9. Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity.
Hu JK; Crampton JC; Cupo A; Ketas T; van Gils MJ; Sliepen K; de Taeye SW; Sok D; Ozorowski G; Deresa I; Stanfield R; Ward AB; Burton DR; Klasse PJ; Sanders RW; Moore JP; Crotty S
J Virol; 2015 Oct; 89(20):10383-98. PubMed ID: 26246566
[TBL] [Abstract][Full Text] [Related]
10. Co-evolution of HIV Envelope and Apex-Targeting Neutralizing Antibody Lineage Provides Benchmarks for Vaccine Design.
Rantalainen K; Berndsen ZT; Murrell S; Cao L; Omorodion O; Torres JL; Wu M; Umotoy J; Copps J; Poignard P; Landais E; Paulson JC; Wilson IA; Ward AB
Cell Rep; 2018 Jun; 23(11):3249-3261. PubMed ID: 29898396
[TBL] [Abstract][Full Text] [Related]
11. Diverse antibody genetic and recognition properties revealed following HIV-1 envelope glycoprotein immunization.
Phad GE; Vázquez Bernat N; Feng Y; Ingale J; Martinez Murillo PA; O'Dell S; Li Y; Mascola JR; Sundling C; Wyatt RT; Karlsson Hedestam GB
J Immunol; 2015 Jun; 194(12):5903-14. PubMed ID: 25964491
[TBL] [Abstract][Full Text] [Related]
12. Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design.
Gorman J; Soto C; Yang MM; Davenport TM; Guttman M; Bailer RT; Chambers M; Chuang GY; DeKosky BJ; Doria-Rose NA; Druz A; Ernandes MJ; Georgiev IS; Jarosinski MC; Joyce MG; Lemmin TM; Leung S; Louder MK; McDaniel JR; Narpala S; Pancera M; Stuckey J; Wu X; Yang Y; Zhang B; Zhou T; ; Mullikin JC; Baxa U; Georgiou G; McDermott AB; Bonsignori M; Haynes BF; Moore PL; Morris L; Lee KK; Shapiro L; Mascola JR; Kwong PD
Nat Struct Mol Biol; 2016 Jan; 23(1):81-90. PubMed ID: 26689967
[TBL] [Abstract][Full Text] [Related]
13. Complete functional mapping of infection- and vaccine-elicited antibodies against the fusion peptide of HIV.
Dingens AS; Acharya P; Haddox HK; Rawi R; Xu K; Chuang GY; Wei H; Zhang B; Mascola JR; Carragher B; Potter CS; Overbaugh J; Kwong PD; Bloom JD
PLoS Pathog; 2018 Jul; 14(7):e1007159. PubMed ID: 29975771
[TBL] [Abstract][Full Text] [Related]
14. Functional Stability of HIV-1 Envelope Trimer Affects Accessibility to Broadly Neutralizing Antibodies at Its Apex.
Gift SK; Leaman DP; Zhang L; Kim AS; Zwick MB
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978711
[TBL] [Abstract][Full Text] [Related]
15. A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic β-Hairpin Structure.
Lee JH; Andrabi R; Su CY; Yasmeen A; Julien JP; Kong L; Wu NC; McBride R; Sok D; Pauthner M; Cottrell CA; Nieusma T; Blattner C; Paulson JC; Klasse PJ; Wilson IA; Burton DR; Ward AB
Immunity; 2017 Apr; 46(4):690-702. PubMed ID: 28423342
[TBL] [Abstract][Full Text] [Related]
16. Mutational fitness landscapes reveal genetic and structural improvement pathways for a vaccine-elicited HIV-1 broadly neutralizing antibody.
Madan B; Zhang B; Xu K; Chao CW; O'Dell S; Wolfe JR; Chuang GY; Fahad AS; Geng H; Kong R; Louder MK; Nguyen TD; Rawi R; Schön A; Sheng Z; Nimrania R; Wang Y; Zhou T; Lin BC; Doria-Rose NA; Shapiro L; Kwong PD; DeKosky BJ
Proc Natl Acad Sci U S A; 2021 Mar; 118(10):. PubMed ID: 33649208
[TBL] [Abstract][Full Text] [Related]
17. A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques.
Jones AT; Chamcha V; Kesavardhana S; Shen X; Beaumont D; Das R; Wyatt LS; LaBranche CC; Stanfield-Oakley S; Ferrari G; Montefiori DC; Moss B; Tomaras GD; Varadarajan R; Amara RR
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237847
[TBL] [Abstract][Full Text] [Related]
18. Differential induction of anti-V3 crown antibodies with cradle- and ladle-binding modes in response to HIV-1 envelope vaccination.
Balasubramanian P; Kumar R; Williams C; Itri V; Wang S; Lu S; Hessell AJ; Haigwood NL; Sinangil F; Higgins KW; Liu L; Li L; Nyambi P; Gorny MK; Totrov M; Nadas A; Kong XP; Zolla-Pazner S; Hioe CE
Vaccine; 2017 Mar; 35(10):1464-1473. PubMed ID: 28185743
[TBL] [Abstract][Full Text] [Related]
19. Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller.
Freund NT; Wang H; Scharf L; Nogueira L; Horwitz JA; Bar-On Y; Golijanin J; Sievers SA; Sok D; Cai H; Cesar Lorenzi JC; Halper-Stromberg A; Toth I; Piechocka-Trocha A; Gristick HB; van Gils MJ; Sanders RW; Wang LX; Seaman MS; Burton DR; Gazumyan A; Walker BD; West AP; Bjorkman PJ; Nussenzweig MC
Sci Transl Med; 2017 Jan; 9(373):. PubMed ID: 28100831
[TBL] [Abstract][Full Text] [Related]
20. Diverse Murine Vaccinations Reveal Distinct Antibody Classes to Target Fusion Peptide and Variation in Peptide Length to Improve HIV Neutralization.
Sastry M; Changela A; Gorman J; Xu K; Chuang GY; Shen CH; Cheng C; Geng H; O'Dell S; Ou L; Rawi R; Reveiz M; Stewart-Jones GBE; Wang S; Zhang B; Zhou T; Biju A; Chambers M; Chen X; Corrigan AR; Lin BC; Louder MK; McKee K; Nazzari AF; Olia AS; Parchment DK; Sarfo EK; Stephens T; Stuckey J; Tsybovsky Y; Verardi R; Wang Y; Zheng CY; Chen Y; Doria-Rose NA; McDermott AB; Mascola JR; Kwong PD
J Virol; 2023 May; 97(5):e0160422. PubMed ID: 37098956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
